Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Change in Accured Expenses: 2014-2025

Historic Change in Accured Expenses for Fennec Pharmaceuticals (FENC) over the last 11 years, with Sep 2025 value amounting to $1.5 million.

  • Fennec Pharmaceuticals' Change in Accured Expenses rose 436.73% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $388,000, marking a year-over-year decrease of 72.36%. This contributed to the annual value of -$326,000 for FY2024, which is 156.60% down from last year.
  • Fennec Pharmaceuticals' Change in Accured Expenses amounted to $1.5 million in Q3 2025, which was up 338.83% from -$618,000 recorded in Q2 2025.
  • Fennec Pharmaceuticals' 5-year Change in Accured Expenses high stood at $1.8 million for Q4 2023, and its period low was -$1.3 million during Q2 2024.
  • Over the past 3 years, Fennec Pharmaceuticals' median Change in Accured Expenses value was -$75,000 (recorded in 2023), while the average stood at $47,545.
  • Per our database at Business Quant, Fennec Pharmaceuticals' Change in Accured Expenses surged by 1,352.73% in 2021 and then plummeted by 1,666.67% in 2024.
  • Quarterly analysis of 5 years shows Fennec Pharmaceuticals' Change in Accured Expenses stood at $689,000 in 2021, then fell by 18.62% to $1.8 million in 2022, then climbed by 1.10% to $1.8 million in 2023, then slumped by 93.77% to $115,000 in 2024, then surged by 436.73% to $1.5 million in 2025.
  • Its Change in Accured Expenses stands at $1.5 million for Q3 2025, versus -$618,000 for Q2 2025 and -$585,000 for Q1 2025.